BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 27324705)

  • 1. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
    Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
    J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between serum uric acid related genetic loci and diabetic kidney disease in the Chinese type 2 diabetes patients.
    Yan D; Wang J; Jiang F; Zhang R; Sun X; Wang T; Wang S; Peng D; He Z; Bao Y; Hu C; Jia W
    J Diabetes Complications; 2016 Jul; 30(5):798-802. PubMed ID: 26993665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between decreased thyroid stimulating hormone and hyperuricemia in type 2 diabetic patients with early-stage diabetic kidney disease.
    Feng X; Huang J; Peng Y; Xu Y
    BMC Endocr Disord; 2021 Jan; 21(1):1. PubMed ID: 33407357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.
    Afkarian M; Polsky S; Parsa A; Aronson R; Caramori ML; Cherney DZ; Crandall JP; de Boer IH; Elliott TG; Galecki AT; Goldfine AB; Haw JS; Hirsch IB; Karger AB; Lingvay I; Maahs DM; McGill JB; Molitch ME; Perkins BA; Pop-Busui R; Pragnell M; Rosas SE; Rossing P; Senior P; Sigal RJ; Spino C; Tuttle KR; Umpierrez GE; Wallia A; Weinstock RS; Wu C; Mauer M; Doria A;
    Diabetes Care; 2019 Aug; 42(8):1454-1463. PubMed ID: 31186299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population.
    Liu J; Yang W; Li Y; Wei Z; Dan X
    BMC Med Genet; 2020 Mar; 21(1):54. PubMed ID: 32183743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease.
    Ghane Sharbaf F; Assadi F
    Pediatr Nephrol; 2018 Aug; 33(8):1405-1409. PubMed ID: 29549464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.
    Wen CC; Yee SW; Liang X; Hoffmann TJ; Kvale MN; Banda Y; Jorgenson E; Schaefer C; Risch N; Giacomini KM
    Clin Pharmacol Ther; 2015 May; 97(5):518-25. PubMed ID: 25676789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome wide association study of uric acid in Indian population and interaction of identified variants with Type 2 diabetes.
    Giri AK; Banerjee P; Chakraborty S; Kauser Y; Undru A; Roy S; Parekatt V; Ghosh S; Tandon N; Bharadwaj D
    Sci Rep; 2016 Feb; 6():21440. PubMed ID: 26902266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 Diabetes.
    Jiang G; Luk AO; Tam CHT; Ozaki R; Lim CKP; Chow EYK; Lau ES; Kong APS; Fan B; ; Lee KF; Siu SC; Hiu G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; ; Tang NLS; Huang Y; Lan HY; Oram RA; Szeto CC; So WY; Chan JCN; Ma RCW
    Diabetes; 2022 Mar; 71(3):520-529. PubMed ID: 35043149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febuxostat is superior to allopurinol in delaying the progression of renal impairment in patients with chronic kidney disease and hyperuricemia.
    Zhang X; Wan D; Yang G; Peng Q; Wang X
    Int Urol Nephrol; 2019 Dec; 51(12):2273-2283. PubMed ID: 31646459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in the association between hyperuricemia and diabetic kidney disease in community elderly patients.
    Guo M; Niu JY; Li SR; Ye XW; Fang H; Zhao YP; Gu Y
    J Diabetes Complications; 2015; 29(8):1042-9. PubMed ID: 26387809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of hyper-uricaemia and low urinary uric acid excretion further increases risk of chronic kidney disease in type 2 diabetes.
    Chen MY; Wang AP; Wang JW; Ke JF; Yu TP; Li LX; Jia WP
    Diabetes Metab; 2019 Dec; 45(6):557-563. PubMed ID: 30928248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study.
    Chang YH; Lei CC; Lin KC; Chang DM; Hsieh CH; Lee YJ
    Diabetes Metab Res Rev; 2016 Sep; 32(6):557-64. PubMed ID: 26590369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum bilirubin levels s and the progression of renal function in patients with chronic kidney disease and hyperuricemia.
    Li M; Li X; Liu Y; Liu X; Song Y; Zhao J; Mohan C; Wu T; Peng A; Qin L
    Clin Chim Acta; 2018 Nov; 486():156-161. PubMed ID: 30076802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes.
    Sheikhbahaei S; Fotouhi A; Hafezi-Nejad N; Nakhjavani M; Esteghamati A
    Metab Syndr Relat Disord; 2014 Mar; 12(2):102-9. PubMed ID: 24447037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.